Get started
MADRIGAL PHARMACEUTICALS INCMADRIGAL PHARMACEUTICALS INCMADRIGAL PHARMACEUTICALS INC

MADRIGAL PHARMACEUTICALS INC

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

YDO1 chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪4.51 B‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−21.39EUR
Net income (FY)
‪−338.51 M‬EUR
Revenue (FY)
—
Shares float
‪17.38 M‬
Beta (1Y)
1.84

About Madrigal Pharmaceuticals, Inc.

Sector
Health Technology
CEO
William J. Sibold
Headquarters
West Conshohocken
Website
madrigalpharma.com
Employees (FY)
376
Founded
2011
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of YDO1 is 213.20 EUR — it has increased by 0.90% in the past 24 hours. Watch MADRIGAL PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange MADRIGAL PHARMACEUTICALS INC stocks are traded under the ticker YDO1.
YDO1 stock has risen by 5.13% compared to the previous week, the month change is a 17.99% rise, over the last year MADRIGAL PHARMACEUTICALS INC has showed a 18.97% decrease.
We've gathered analysts' opinions on MADRIGAL PHARMACEUTICALS INC future price: according to them, YDO1 price has a max estimate of 467.50 EUR and a min estimate of 138.31 EUR. Watch YDO1 chart and read a more detailed MADRIGAL PHARMACEUTICALS INC stock forecast: see what analysts think of MADRIGAL PHARMACEUTICALS INC and suggest that you do with its stocks.
YDO1 reached its all-time high on Mar 15, 2024 with the price of 299.90 EUR, and its all-time low was 0.04 EUR and was reached on Nov 10, 2005. View more price dynamics on YDO1 chart.
See other stocks reaching their highest and lowest prices.
YDO1 stock is 1.13% volatile and has beta coefficient of 1.84. Track MADRIGAL PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is MADRIGAL PHARMACEUTICALS INC there?
Today MADRIGAL PHARMACEUTICALS INC has the market capitalization of ‪4.51 B‬, it has increased by 13.88% over the last week.
Yes, you can track MADRIGAL PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
MADRIGAL PHARMACEUTICALS INC is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
YDO1 earnings for the last quarter are −6.84 EUR per share, whereas the estimation was −5.76 EUR resulting in a −18.64% surprise. The estimated earnings for the next quarter are −6.91 EUR per share. See more details about MADRIGAL PHARMACEUTICALS INC earnings.
MADRIGAL PHARMACEUTICALS INC revenue for the last quarter amounts to 0 EUR despite the estimated figure of 0 EUR. In the next quarter revenue is expected to reach ‪3.58 M‬ EUR.
YDO1 net income for the last quarter is ‪−136.74 M‬ EUR, while the quarter before that showed ‪−101.65 M‬ EUR of net income which accounts for −34.52% change. Track more MADRIGAL PHARMACEUTICALS INC financial stats to get the full picture.
No, YDO1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 27, 2024, the company has 376.00 employees. See our rating of the largest employees — is MADRIGAL PHARMACEUTICALS INC on this list?
Like other stocks, YDO1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MADRIGAL PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MADRIGAL PHARMACEUTICALS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MADRIGAL PHARMACEUTICALS INC stock shows the buy signal. See more of MADRIGAL PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.